Cargando…

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

Peritoneal dissemination is a distinct form of metastasis in ovarian cancer that precedes hematogenic or lymphatic metastasis. Exosomes are extracellular vesicles of 30–150 nm in diameter secreted by different cell types and internalized by target cells. There is emerging evidence that exosomes faci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Koji, Sawada, Kenjiro, Kobayashi, Masaki, Miyamoto, Mayuko, Shimizu, Aasa, Yamamoto, Misa, Kinose, Yasuto, Kimura, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721530/ https://www.ncbi.nlm.nih.gov/pubmed/31405096 http://dx.doi.org/10.3390/cancers11081147

Ejemplares similares

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
por: Nakamura, Koji, et al.
Publicado: (2019)

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer
por: Shimizu, Aasa, et al.
Publicado: (2020)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

The Role of MicroRNAs in Ovarian Cancer
por: Kinose, Yasuto, et al.
Publicado: (2014)

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types
por: Kobayashi, Masaki, et al.
Publicado: (2018)

Clinical relevance of circulating cell-free microRNAs in ovarian cancer
por: Nakamura, Koji, et al.
Publicado: (2016)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)
por: Oride, Tadashi, et al.
Publicado: (2023)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma
por: Kinose, Yasuto, et al.
Publicado: (2015)

Safety and efficacy of Ninjin’yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
por: Yagi, Taro, et al.
Publicado: (2022)

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
por: Kobayashi, Masaki, et al.
Publicado: (2017)

Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
por: Isobe, Aki, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017)

A single institution’s experience with minimally invasive surgery for ovarian cancer, and a systematic meta-analysis of the literature
por: Kamei, Yuji, et al.
Publicado: (2023)

Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer
por: Sawada, Kenjiro, et al.
Publicado: (2012)

Laparoscopic spacer placement for bulky lymph node metastasis of cervical cancer: A case report
por: Kuruma, Airi, et al.
Publicado: (2022)

Stinging abdominal pain at 32 gestational weeks with prior classical uterine incision: Careful assessment or emergency cesarean delivery?
por: Kakigano, Aiko, et al.
Publicado: (2021)

Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum
por: Mimura, Kazuya, et al.
Publicado: (2017)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing
por: Sumitani, Naoki, et al.
Publicado: (2022)

Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy
por: Kuruma, Airi, et al.
Publicado: (2022)

Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
por: Shen, Jiayu, et al.
Publicado: (2018)

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy
por: Yoshimura, Akihiko, et al.
Publicado: (2018)

H2Bub1 loss is an early contributor to clear cell ovarian cancer progression
por: Ferrari, Adam J., et al.
Publicado: (2023)

Design strategies and application progress of therapeutic exosomes
por: Liu, Chunying, et al.
Publicado: (2019)

Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination
por: Kawata, Mayuko, et al.
Publicado: (2022)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer
por: Shiomi, Mayu, et al.
Publicado: (2021)

The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies
por: Wang, Haobing, et al.
Publicado: (2022)

A case of laparoscopic surgery for endometrial cancer in a patient previously treated with a transvaginal mesh procedure for pelvic organ prolapse
por: Yoshino, Kiyoshi, et al.
Publicado: (2017)

The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Therapeutic Effect
por: Xian Bo, Shang, et al.
Publicado: (2022)

Editorial: Exploring the role of exosomes in disease progression and therapeutics in neurodegeneration
por: Jan, Arif Tasleem, et al.
Publicado: (2023)

A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies
por: Cheng, Lin, et al.
Publicado: (2017)

Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer
por: Malgundkar, Shika Hanif, et al.
Publicado: (2023)

Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications
por: Ren, Xiaoyu, et al.
Publicado: (2023)

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters
por: Isohashi, Fumiaki, et al.
Publicado: (2015)

CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer
por: Nagoya, Akihiro, et al.
Publicado: (2023)

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
por: Tanaka, Yusuke, et al.
Publicado: (2018)

Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities
por: Wandrey, Madita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bsclo07jpum2sqgbeah9p99mtn